Neidio i'r prif gynnwys

Attendees

Sarah Carr (SC) Vet & Farmer/Animal Health & Welfare Framework Representative
Rob Smith (RS) Iechy Da/Arwain DGC
Kitty Healey (KH) Veterinary Medicines Directorate (VMD)
Meryl Davies (MD) Public Health Wales (PHW)
Catrin Moore (CM) Microbiology Society
Ifan Lloyd (IL) Iechyd Da/Arwain DGC
Alice Lampard (AL) Animal and Plant Health Agency (APHA)
Richard Pizzey (RP) OCVO, Welsh Government
Sian Timms (ST) OCVO, Welsh Government
Kirsty Falcus (KF) OCVO, Welsh Government
Simon Rolfe (SR) HSS, Welsh Government
Carol Willis (CW) HSS, Welsh Government
Naheeda Portocarero (NP) Feed, Food & Future Ltd
Joshua Macleod (JM) Feed, Food & Future Ltd
Kristen Reyher (KR) University of Bristol
Elliot Stanton (ES) University of Bristol
Don Thomas (DT) Welsh Lamb & Beef Producers
Iestyn Tudur-Jones (IT) Welsh Lamb & Beef Producers
Llyr Lewis (LL) Welsh Lamb & Beef Producers
Dewi Hughes (DH) Arwain DGC

Apologies

Gwen Rees (GR) Aberystwyth University/Arwain DGC
Hywel Morgan (HM) Farmer
Thomas Bletcher (TB) Farmer
Ifan Davies (ID) YFC Representative
Chris Teale (CT) Animal and Plant Health Agency (APHA)

Facilitator(s): please contact waeamrdg@gov.wales
    
KEY
* = DG Board Member
^ = Technical issues

Welcome and Introductions: Richard Pizzey

The chair welcomed attendees to the sixth meeting of the group, noted that some members were absent, and recorded one formal apology from Gwen. It was also noted that several new faces were present, mainly due to guest speakers joining for specific agenda items.

The agenda was described as busy and focused, with key items covering the AMU calculator and approaches to reducing livestock antibiotic resistance. Full introductions were not undertaken at the start of the meeting; instead, the chair explained that speakers would be introduced as their agenda items arose.

Arwain AMU Calculator Progress Update: WLBP/UoB

The WLBP and Bristol University presentation provided an update on the antimicrobial usage (AMU) calculator, analysis of AMU and antimicrobial resistance (AMR) data, and the emerging insights this work offers for policy, practice and stewardship in Wales. WLBP represents around 6,500 farmers and captures data covering a significant proportion of Welsh livestock. The AMU calculator is embedded in farm assurance standards and has been mandatory since 2021 as part of annual vet-led health and welfare reviews. It brings together farm livestock data and antibiotic usage data drawn directly from veterinary practice systems, creating a standardised multi-year dataset dating back to around 2019, with thousands of calculations completed each year.

The system provides a strong basis for benchmarking, trend analysis, farm-level decision making, policy reporting and supply chain assurance. Bristol University’s analysis shows that overall antibiotic use in Wales is below UK industry targets, although there is significant variation between farms and high or low usage is not always consistent from year to year. Key drivers include lameness in sheep, respiratory disease and lameness in beef, and mastitis in dairy. Farms using best-practice management approaches, such as lameness control, tend to show lower antibiotic use, suggesting that targeted health and welfare interventions can support responsible prescribing.

The analysis also identified opportunities to refine prescribing and treatment guidance. Around 2.5% of usage may not clearly align with licensed indications, with approximately one in ten farms showing some level of this pattern. The highest-usage quartile of farms accounts for more than half of total usage and is also associated with greater use of higher-priority antibiotics, indicating that targeted support for this group could deliver meaningful benefits. AMR analysis, supported by extensive environmental sampling, is enabling longitudinal assessment of resistance. Early findings suggest that weather may influence AMR detection, with warmer conditions linked to a higher likelihood of resistance, and that reductions in use may be associated with reduced resistance for some antibiotics, although trends are not consistent across all species or compounds.

The presentation also highlighted watery mouth in sheep as an example where management improvements could reduce antibiotic reliance. Around 20% of farmers reported using oral antibiotics preventatively, while treatment patterns vary considerably, with most farmers treating low proportions of lambs but around 10% treating very high proportions with injectables. Inconsistent monitoring of colostrum intake and quality was identified as a management gap, reinforcing the opportunity to reduce antibiotic use through improved husbandry and disease prevention.

The group discussion focused on how to translate this evidence base into practical action, policy alignment and improved outcomes on farm. Richard Pizzey welcomed the proactive approach being taken by the Welsh beef sector on animal health and welfare and described the AMU calculator as a valuable tool for opening conversations with farmers, particularly where routine veterinary contact is limited. Rob Smith confirmed it is still widely used in practice, has become much smoother since its early stages, and is now a crucial part of health planning for both farm-assured and non-farm-assured Welsh livestock farms.

Richard linked this to the Sustainable Farming Scheme (SFS), noting the need to avoid duplicating farm assurance requirements or undermining AMU calculator data collection. He suggested future discussion on how the SFS optional and collaborative layers could support practical AMR and antimicrobial-usage improvements. Meryl Davies said data should be used for action, helping farmers identify the conditions driving antibiotic use and put targeted interventions into animal health plans, such as pneumonia vaccination or lameness control. She also suggested quantifying carbon savings from reduced antibiotic use, as is being explored in human health. Don Thomas agreed that medicines are a carbon input and said carbon impacts are already being considered through AMR/AMU data work.

Rob Smith emphasised that Arwain DGC partners want the work to create a real legacy on farm, not simply collect data. He suggested an action for the delivery group to meet Arwain DGC partners to align their work with SFS and Welsh Government policy. Richard agreed and said he would follow up with Dewi.

Kitty Healey asked about the AMR modelling and weather implications, including whether the findings were phenotypic or genotypic, whether the weather association was likely to be real, and what it meant for surveillance. Elliot Stanton explained that the data discussed were phenotypic, although genotypic data also exist. He said there is likely to be a real association between weather and AMR, though the pathways remain unclear, and warned that surveillance results could be biased if sampling is not spread across different weather conditions. Kitty noted this reinforced the need for year-round sampling and may help explain higher AMR results in warmer countries. Elliot agreed the local-level data help separate climate effects from differences in practice.

Alice Lampard asked whether the AMR work had examined sensitivity testing and whether category B antibiotics were being used first line or following test results. Kristen Reyher said the management questionnaires covered only 70 mixed farms and did not appear to ask this directly. Her impression was that beef, and sheep producers undertake limited sensitivity testing, with dairy perhaps doing more. She said diagnostic testing could support stewardship, but prescribing behaviour is affected by risk aversion, and clinicians may still prescribe when test results are unclear. Richard suggested farm vets and farmers might be more open to tools at population level, but Kristen cautioned that risk aversion and confidence in tests remain important behavioural barriers.

Ifan Lloyd asked how the positive story around Welsh AMU data could be communicated to consumers and used to gain recognition for the sector, particularly in response to anti-farming or anti-livestock narratives. Don Thomas said this is a significant opportunity, especially in the context of trade deals, and that AMU/EMU data provide strong real-world evidence to support Welsh and British production standards. He said industry and government would need to work together on public messaging, including highlighting the very low use of critical antibiotics.

Catrin Moore asked about possible time lags between antimicrobial exposure and observed resistance. Elliot clarified that the graph showed spectinomycin resistance, not AMU data, and said the study may have missed the earlier period of highest usage. His farm-level work suggests a possible six-month period where AMU is most strongly related to resistance, but the results are noisy and limited by sample size.

Meryl asked whether WLBP usage data could be combined with resistance data for the 70 farms to guide farm-specific antibiotic choices. Kristen said this was complex but promising: resistance profiles could help vets avoid antibiotics with higher resistance and choose narrower, more effective options. Elliot said farm-level phenotypic resistance can be modelled reasonably well, although direct links to AMU remain early-stage and noisy. Meryl emphasised that effective first-line treatment could reduce disease spread, treatment failure and repeat antibiotic use. Kristen agreed and said the team would look further at individual farm-level use of resistance and usage data.

Reducing Livestock Antibiotic Reliance through Antiviral Product Screening: Joshua Macleod/Naheeda Portocarero

Naheeda Portocarero and Joshua Macleod outlined Feed Food & Future’s work to reduce antimicrobial resistance by developing antiviral and other alternative interventions for livestock systems, particularly pigs and poultry. The central premise is that controlling viral disease earlier can reduce secondary bacterial infections and therefore reduce the need for antibiotic treatment. The organisation works across research, consultancy and industry collaboration, with biosafety level 2 laboratory capability for microbiology, virology, antimicrobial and antiviral testing, and partnerships with Cardiff Metropolitan University, the University of South Wales and the Pirbright Institute.

The presentation highlighted that secondary infection following primary viral disease is an important driver of antibiotic use. Current research focuses on identifying compounds with antiviral activity that could be used in feed or within the farm environment, including plant extracts, botanical compounds, organic acids, minerals and other alternative agents. Viruses under study include porcine reproductive and respiratory syndrome, swine influenza and rotavirus. Laboratory assessment uses in vitro approaches such as virus neutralisation tests and cell culture models, although biological variability means repeated experiments and multiple data sources are needed to confirm findings.

A strong stewardship theme ran through the presentation: alternatives must reduce disease pressure without creating new antimicrobial resistance risks or cross-resistance with clinically important antibiotics. The work therefore includes resistance studies, monitoring genetic mutations and assessing horizontal gene transfer. Previous research has tested more than 30 compounds against bacterial pathogens, with some findings already adopted in UK and EU livestock sectors. Future work will focus on moving promising findings towards practical application, including feed additives, on-farm interventions, further assessment of resistance impacts, bacteriophage development and other innovations such as methane reduction products.

The discussion explored how promising interventions could move from research into practical use, particularly within the Welsh context. Although the work is primarily focused on pigs, a sector less prominent in Wales, the group noted that pigs can provide a useful testing ground because preventative health approaches are often more advanced than in beef and sheep systems. Lessons may therefore be transferable to other sectors, provided they are supported by robust evidence and clear guidance.

Regulatory complexity was identified as a key issue. The pathway from research to on-farm use can be lengthy and resource-intensive, requiring toxicology, safety and approval processes. The group discussed the distinction between feed additives, regulated by the Food Standards Agency, and veterinary medicinal products, regulated by the Veterinary Medicines Directorate, noting that some products may fall into borderline categories depending on their use. Early regulator engagement was therefore seen as essential, particularly for novel approaches such as bacteriophages, although existing compounds such as botanicals may benefit from shorter approval routes where there is prior evidence of safe use.

The group also reflected on previous experience with alternative products, where insufficient evidence or poor application had reduced farmer confidence. Presenters emphasised the need for evidence-based guidance on when and how interventions should be used, alongside checks to ensure alternatives do not themselves contribute to resistance. Overall, the work was seen as a promising preventative approach to AMR, aligned with One Health principles and wider disease control activity. Further collaboration with policy teams, regulators and existing programmes could help align future development with delivery mechanisms and ensure that any innovations support practical, farm-level disease prevention.

Roundtable Updates

DG Members

Meryl Davies

Meryl provided an update on human health antimicrobial stewardship (AMS), noting continued work to review and develop guidance, provide quarterly data reporting to support improvement in antimicrobial use, and complete evaluation of data outputs while survey analysis continues. She highlighted the appointment of Dan Phillips as the new secondary care lead pharmacist and ongoing work to strengthen secondary care AMS activity, alongside planning for 2026–2027 AMS campaigns and opportunities for One Health messaging, including possible engagement at the Royal Welsh Show. A new workstream will also assess the wider benefits of stewardship interventions, including financial, clinical and environmental impacts such as carbon footprint, to demonstrate how AMS contributes to the broader sustainability agenda.

Ifan Lloyd

Ifan provided an update in his role representing the group on the Cattle Antibiotic Guardian Group, highlighting increasing concern around antibiotic use in calves. He noted that VMD-funded work is underway, delivered by SRUC, to better understand and address calf antibiotic use, and that the Arwain DGC project is also working with Liverpool University through FAVSNET to analyse data and identify trends. Calf antibiotic use was therefore identified as an emerging priority area, with new research and data analysis expected to inform future interventions.

Rob Smith

Rob provided an update on progress across Arwain DGC, VPC Network activity and surveillance initiatives, noting that final 2025–26 reports have been submitted to Welsh Government and that recent partner discussions have emphasised stronger collaboration, clearer communication and a greater focus on tangible on-farm impact and legacy, including a shift towards engaging farmers through vets. He highlighted good attendance at the May VPC Network conference, ongoing work on practice and vet benchmarking, increased One Health collaboration with human health colleagues, and improved engagement with companion animal and equine sectors. Innovation funding support continues to provide farmers and vets with tools to improve animal health, welfare and productivity, while FAVSNET activity is expanding geographical coverage, improving links with practice management systems and collecting syndromic surveillance and daily antibiotic usage data, with the aim of cross-referencing this with WLBP/Bristol datasets to give a more comprehensive and real-time picture of antibiotic use and disease trends. Discussions are also underway with Welsh Government and partners on scanning surveillance systems such as FAVSNET, SAVSNET and EVSNET nationally, with engagement continuing to support this ambition, and the Arwain DGC Conference is scheduled for 18–19 November in Cardiff during World Antimicrobial Resistance Awareness Week.

Alice Lampard

Alice provided a brief business-as-usual update, noting that current priorities are focused on AMR data analysis for the VARSS report, with data submission to the Veterinary Medicines Directorate underway and further analysis continuing ahead of publication later in the year. She also highlighted laboratory testing developments, including the transition from disc diffusion testing to MIC testing; laboratory validation is largely complete, with remaining work focused on IT system development to support reporting, although some delays have been encountered in the IT build and reporting functionality.

Catrin Moore

Catrin provided an update from the Microbiology Society, highlighting recent AMR policy activity, ongoing publication work and increasing focus on environmental AMR and surveillance. She noted that a major April meeting included AMR policy discussions and a workshop, with outputs now being written up, while a comprehensive 15-chapter AMR roadmap is currently undergoing peer review ahead of publication. Planning is also underway for the next Microbiology Society meeting, likely to focus on sewage and water-related AMR issues, and recent pilot work has tested water quality at coastal locations, including in Wales, using point-of-care methods to detect sewage contamination. Findings from this work are not yet published but are expected to be shared in future, although progress on some activities has been affected by a significant ongoing IT incident restricting access to data.

Welsh Government: Richard Pizzey

The Welsh Government update highlighted the current policy context, programme priorities and emerging areas of AMR work, with AMR expected to remain a stable and important policy area under the new Welsh Government administration and continuing ministerial interest. Recent work includes completion of a PhD placement reviewing the companion animal AMR landscape, which identified priority areas for intervention and areas where duplication should be avoided, with a potential procurement exercise being considered to take forward targeted activity. Environmental AMR surveillance is also being explored through engagement with Bangor University and Public Health Wales on wastewater monitoring at treatment plants and hospital sites, alongside early consideration of possible abattoir wastewater pilot work, although interpretation of findings and appropriate government responses remain key challenges.

Additional capacity has been strengthened by the appointment of Alice Moore as a new veterinary adviser, with a formal introduction expected at a future meeting. The ongoing Sustainable Farming Scheme red tape review may create opportunities to strengthen AMR and animal health elements, and the group’s input could help shape future SFS actions and interventions. The next phase of BVD legislation is also due to go live shortly, providing a potential opportunity to assess the impact of disease control programmes on antimicrobial usage and explore links between eradication activity and AMR reduction. Overall, Welsh Government is well placed to build on existing AMR work by embedding AMR within future agricultural policy frameworks, expanding into companion animal and environmental AMR, and strengthening evidence-led interventions and cross-sector collaboration.

One Health Update: Simon Rolfe

Simon provided an update on UK-wide AMR programme activity, noting ongoing discussions about prioritising delivery against the National Action Plan as it may be challenging to deliver all commitments in full. He highlighted the growing importance of behavioural science in AMR interventions, recognising that decisions such as prescribing and diagnostic use are influenced by human behaviour as well as evidence, and that effective stewardship approaches therefore need to address both clinical and behavioural drivers. He also noted increasing interest in microbiome research, while emphasising the complexity, resource requirements and long-term evidence base needed to establish causal relationships.

Simon also reported that Wales contributed two case studies, the Arwain DGC programme and the WLBP AMU calculator, to the Year 2 National Action Plan progress report, helping to showcase Welsh strengths and innovation within the wider UK programme. He highlighted continued efforts to strengthen One Health integration across human, animal and environmental health, including an offer to support future discussions or workshops, and noted an emerging focus on system-level AMR risks, such as impacts on critical services and infrastructure. The update concluded that AMR delivery is moving towards a more strategic and prioritised approach, with opportunities to strengthen cross-sector collaboration, embed behavioural insights and improve understanding of system vulnerabilities and resilience.

Veterinary Medicines Directorate (VMD): Kitty Healey

Kitty provided an update from the Veterinary Medicines Directorate, covering progress across AMR surveillance, data collection, stewardship activity, international engagement and communications. Work is progressing on the next VARSS report, and the Private Laboratories Initiative has secured two further years of funding through the Integrated Security Fund to expand AMR data collection from private veterinary laboratories, with potential to move beyond pilot activity into business-as-usual integration. New and upcoming surveillance work includes the BioBorders project on AMR in foodborne pathogens and imported raw pet food ingredients, planning for a UK-wide AMR in cattle survey in 2027, and ongoing pilot work on AMR in healthy cats and dogs, including faecal sampling. Kitty also noted continued engagement on the Ruminant Roadmap, ongoing challenges in collecting antibiotic usage data from cattle and sheep sectors, progress with equine antibiotic use data collection and benchmarking through the Monitor Me programme, and wider work to support sector-specific stewardship targets.

On policy and international engagement, Kitty highlighted the UK’s continued presence at international level, including a CVO-led AMR forum held at an international meeting in May and ongoing efforts to maintain UK leadership and collaboration, particularly with low- and middle-income countries. The planned ministerial AMR conference in Nigeria has been postponed because of regional health concerns linked to an Ebola outbreak, with a new date yet to be confirmed. Communications activity also continues, including engagement with public-facing AMR awareness initiatives such as the Lifeline musical, while the key themes remain strengthening surveillance infrastructure, improving cross-species monitoring and addressing persistent data collection challenges in ruminant sectors.

Closing Remarks: Richard Pizzey

The meeting ended at 12:40 with no AOB covered in the meeting.